← FDA DRUG APPROVALS

FDA NDA · NDA010441

RESERPINE

Sponsor: EVERYLIFE

APPLICATION
NDA010441
TYPE
NDA
LATEST ACTION
1980-01-03
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

RESERPINEDiscontinued
RESERPINE 1MG · TABLET · ORAL
RESERPINEDiscontinued
RESERPINE 0.25MG · TABLET · ORAL
RESERPINEDiscontinued
RESERPINE 0.5MG · TABLET · ORAL
RESERPINEDiscontinued
RESERPINE 0.1MG · TABLET · ORAL

Approval history

1980-01-03Labeling · Supplement 7AP
1978-02-21Manufacturing (CMC) · Supplement 6 · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →